Postherpetic Neuralgia

• FDA approval · 2009-12-15
  FDA Approved: CARBAMAZEPINE — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for Carbamazepine (generic) submitted by Chartwell RX, LLC.

• FDA approval · 2009-11-20
  FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application for gabapentin from BluePoint Laboratories, granting approval to market a generic gabapentin product…

• FDA approval · 2009-11-16
  FDA Approved: QUTENZA — Original Application (Averitas Pharma Inc)

  FDA approved QUTENZA (capsaicin) 8% patch from Averitas Pharma Inc in its original application for the treatment of postherpetic neuralgia.

• FDA approval · 2007-07-25
  FDA Approved: GABAPENTIN — Original Application (Amneal Pharmaceuticals LLC)

  The FDA approved Amneal Pharmaceuticals LLC's original ANDA for gabapentin, providing a generic version of the anti-epileptic medication. Th…

• FDA approval · 2007-06-21
  FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-12-05
  FDA Approved: GABAPENTIN — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved Actavis Pharma's supplemental application for gabapentin as a generic drug under ANDA 075350.

• FDA approval · 2006-09-13
  FDA Approved: GABAPENTIN — Original Application (Advagen Pharma Ltd)

  The FDA approved Advagen Pharma Ltd's Original Application for gabapentin, enabling a generic version of the anticonvulsant. The approval su…

• FDA approval · 2006-08-24
  FDA Approved: GABAPENTIN — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves Sun Pharmaceutical's gabapentin as an original generic application, allowing market authorization for a gabapentin product.

• FDA approval · 2006-08-24
  FDA Approved: GABAPENTIN — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a generic gabapentin product from Sun Pharmaceutical Industries as an Original Application (ANDA). The approval makes a generic…

• FDA approval · 2006-08-18
  FDA Approved: GABAPENTIN — Original Application (BluePoint Laboratories)

  The FDA approved BluePoint Laboratories' original application for gabapentin (generic). The approval covers its use as a generic option for …

• FDA approval · 2006-05-03
  FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Div of Pfizer Inc.

• FDA approval · 2006-05-03
  FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  The FDA approved a supplemental application for Neurontin (gabapentin) from Parke-Davis Div of Pfizer Inc, resulting in updated labeling.